Tenofovir
(VCMJCVGFSROFHV-WZGZYPNHSA-N)
Structure
- SMILES
- C[C@H](Cn1cnc2c1ncnc2N)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C.OC(=O)/C=C/C(=O)O
- Molecular Formula:
- C23H34N5O14P
- Molecular Weight:
- 635.515
- Log P:
- 3.3286
- Hydrogen Bond Acceptor:
- 19
- Hydrogen Bond Donor:
- 3
- TPSA:
- 269.85
- CAS Number(s):
- 202138-50-9
Synonym(s)
1.
Tenofovir
2.
(R)-9-(2-phosphonylmethoxypropyl)adenine
3.
9-(2-Phosphonomethoxypropyl)adenine
4.
9-(2-Phosphonylmethoxypropyl)adenine
5.
9-(2-Phosphonylmethoxypropyl)adenine, (+-)-isomer
6.
9-(2-Phosphonylmethoxypropyl)adenine, (R)-isomer - T357098
7.
9-(2-Phosphonylmethoxypropyl)adenine, (S)-isomer
8.
9-PMPA (tenofovir)
9.
Tenofovir Disoproxil
10.
Tenofovir Disoproxil Fumarate
11.
Viread
12.
Disoproxil Fumarate, Tenofovir
13.
Disoproxil, Tenofovir
14.
Fumarate, Tenofovir Disoproxil
External Link(s)
| MeSH | D000068698 |
| PubChem Compound | 6398764 |
| ChEBI | 63718 |
| CHEMBL | CHEMBL1486 |
| KEGG | dr:D01982 |
| Therapeutic Target Database | D0R3FP |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Osteoporosis | FAERS: 135 Canada Vigilance: 4 | Canada Vigilance OFFSIDES US FAERS | |
| 2 | Nausea | FAERS: 79 | US FAERS | |
| 3 | Pregnancy | FAERS: 68 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 4 | Drug ineffective | FAERS: 66 Canada Vigilance: 15 | Canada Vigilance US FAERS | |
| 5 | Fatigue | FAERS: 66 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 6 | Blood creatinine increased | FAERS: 57 Canada Vigilance: 2 | Canada Vigilance OFFSIDES US FAERS | |
| 7 | Hepatitis B | FAERS: 53 Canada Vigilance: 42 | Canada Vigilance OFFSIDES US FAERS | |
| 8 | Pain | FAERS: 51 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 9 | Viral load increased | FAERS: 50 Canada Vigilance: 13 | Canada Vigilance US FAERS | |
| 10 | Alanine Aminotransferase Increased | FAERS: 47 Canada Vigilance: 5 | Canada Vigilance OFFSIDES US FAERS | |
| 11 | Maternal exposure during pregnancy | FAERS: 44 | US FAERS | |
| 12 | Headache | FAERS: 41 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 13 | Dizziness | FAERS: 33 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 14 | Malaise | FAERS: 33 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 15 | Weight decreased | FAERS: 32 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 16 | Renal tubular disorder | FAERS: 31 Canada Vigilance: 3 | Canada Vigilance OFFSIDES US FAERS | |
| 17 | Abdominal Pain | FAERS: 30 Canada Vigilance: 2 | Canada Vigilance OFFSIDES US FAERS | |
| 18 | Anxiety | FAERS: 30 | US FAERS | |
| 19 | Asthenia | FAERS: 30 Canada Vigilance: 3 | Canada Vigilance OFFSIDES US FAERS | |
| 20 | Vomiting | FAERS: 30 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 21 | Bone pain | FAERS: 28 | OFFSIDES US FAERS | |
| 22 | Bone density decreased | FAERS: 27 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 23 | Unevaluable event | FAERS: 26 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 24 | Alopecia | FAERS: 23 | US FAERS | |
| 25 | Anhedonia | FAERS: 23 | US FAERS | |
| 26 | Economic problem | FAERS: 23 | US FAERS | |
| 27 | Emotional distress | FAERS: 23 | US FAERS | |
| 28 | Osteopenia | FAERS: 23 | OFFSIDES US FAERS | |
| 29 | Diabetes Mellitus | FAERS: 22 | US FAERS | |
| 30 | Hepatitis B DNA increased | FAERS: 19 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 31 | Osteomalacia | FAERS: 19 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 32 | Aspartate Aminotransferase Increased | FAERS: 18 | US FAERS | |
| 33 | Drug dose omission | FAERS: 18 | US FAERS | |
| 34 | Back Pain | FAERS: 17 | US FAERS | |
| 35 | Blood creatine phosphokinase increased | FAERS: 16 | OFFSIDES US FAERS | |
| 36 | Drug resistance | FAERS: 16 Canada Vigilance: 5 | Canada Vigilance OFFSIDES US FAERS | |
| 37 | Pruritus | FAERS: 16 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 38 | Blood phosphorus decreased | FAERS: 15 | OFFSIDES US FAERS | |
| 39 | Cerebrovascular accident | FAERS: 15 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 40 | Myalgia | FAERS: 15 | US FAERS | |
| 41 | Proteinuria | FAERS: 15 | US FAERS | |
| 42 | Thrombocytopenia | FAERS: 15 | US FAERS | |
| 43 | Chest Pain | FAERS: 14 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 44 | Intentional product use issue | FAERS: 14 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 45 | Pneumonia | FAERS: 14 | US FAERS | |
| 46 | Abdominal discomfort | FAERS: 13 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 47 | Palpitations | FAERS: 13 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 48 | Acute kidney injury | FAERS: 12 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 49 | Arthralgia | FAERS: 12 | US FAERS | |
| 50 | Beta 2 microglobulin urine increased | FAERS: 12 | OFFSIDES US FAERS | |
| 51 | Malaria | FAERS: 12 | US FAERS | |
| 52 | Myocardial Infarction | FAERS: 12 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 53 | Fracture | FAERS: 11 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 54 | Renal tubular acidosis | FAERS: 10 | OFFSIDES US FAERS | |
| 55 | Urticaria | FAERS: 10 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 56 | Constipation | FAERS: 9 | US FAERS | |
| 57 | Creatinine renal clearance decreased | FAERS: 9 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 58 | Dysuria | FAERS: 9 | US FAERS | |
| 59 | Lymphoma | FAERS: 9 | OFFSIDES US FAERS | |
| 60 | Chills | FAERS: 8 | US FAERS | |
| 61 | Deafness | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 62 | Hepatitis B DNA assay positive | FAERS: 8 | US FAERS | |
| 63 | Memory impairment | FAERS: 8 | US FAERS | |
| 64 | Metabolic acidosis | FAERS: 8 | OFFSIDES US FAERS | |
| 65 | Nephrotic Syndrome | FAERS: 8 | OFFSIDES US FAERS | |
| 66 | Overdose | FAERS: 8 | US FAERS | |
| 67 | Rhabdomyolysis | FAERS: 8 | OFFSIDES US FAERS | |
| 68 | jaundice | FAERS: 8 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 69 | Accidental overdose | FAERS: 7 | US FAERS | |
| 70 | Amnesia | FAERS: 7 | US FAERS | |
| 71 | Chromaturia | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 72 | Exposure during breast feeding | FAERS: 7 | US FAERS | |
| 73 | Flatulence | FAERS: 7 | US FAERS | |
| 74 | Gastric ulcer | FAERS: 7 | US FAERS | |
| 75 | Osteolysis | FAERS: 7 | OFFSIDES US FAERS | |
| 76 | Product physical issue | FAERS: 7 | US FAERS | |
| 77 | Suicide attempt | FAERS: 7 | US FAERS | |
| 78 | Ascites | FAERS: 6 | OFFSIDES US FAERS | |
| 79 | Dry skin | FAERS: 6 | US FAERS | |
| 80 | Erectile dysfunction | FAERS: 6 | US FAERS | |
| 81 | Fanconi Syndrome | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 82 | Gastritis | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 83 | General physical health deterioration | FAERS: 6 | OFFSIDES US FAERS | |
| 84 | Intentional dose omission | FAERS: 6 | US FAERS | |
| 85 | Musculoskeletal Pain | FAERS: 6 | US FAERS | |
| 86 | Nephrolithiasis | FAERS: 6 | OFFSIDES US FAERS | |
| 87 | Pathological fracture | FAERS: 6 | US FAERS | |
| 88 | Product use issue | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 89 | Renal tubular necrosis | FAERS: 6 | OFFSIDES US FAERS | |
| 90 | Sepsis | FAERS: 6 | US FAERS | |
| 91 | Therapy cessation | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 92 | Tooth Loss | FAERS: 6 | US FAERS | |
| 93 | Wrong technique in product usage process | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 94 | Blindness | FAERS: 5 | US FAERS | |
| 95 | Blood glucose increased | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 96 | Bronchitis | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 97 | CD4 Lymphocytes Decreased | FAERS: 5 | OFFSIDES US FAERS | |
| 98 | Cardiac Arrest | FAERS: 5 | US FAERS | |
| 99 | Chemotherapy | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 100 | Dehydration | FAERS: 5 | OFFSIDES US FAERS | |
| 101 | Drug exposure during pregnancy | FAERS: 5 | OFFSIDES US FAERS | |
| 102 | Exposure via body fluid | FAERS: 5 | US FAERS | |
| 103 | Genotype drug resistance test positive | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 104 | Glaucoma | FAERS: 5 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 105 | HBV-DNA polymerase increased | FAERS: 5 | US FAERS | |
| 106 | Hepatitis B surface antibody positive | FAERS: 5 | US FAERS | |
| 107 | Hepatitis B surface antigen positive | FAERS: 5 | US FAERS | |
| 108 | Hepatitis | FAERS: 5 Canada Vigilance: 3 | Canada Vigilance OFFSIDES US FAERS | |
| 109 | Hypersensitivity | FAERS: 5 | US FAERS | |
| 110 | Inability to afford medication | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 111 | Mitochondrial toxicity | FAERS: 5 | OFFSIDES US FAERS | |
| 112 | Nephrogenic Diabetes Insipidus | FAERS: 5 | OFFSIDES US FAERS | |
| 113 | Neutropenia | FAERS: 5 | US FAERS | |
| 114 | Peripheral swelling | FAERS: 5 | US FAERS | |
| 115 | Polydactyly | FAERS: 5 | OFFSIDES US FAERS | |
| 116 | Polyneuropathy | FAERS: 5 | US FAERS | |
| 117 | Tremor | FAERS: 5 | US FAERS | |
| 118 | Accidental exposure to product | FAERS: 4 | US FAERS | |
| 119 | Ammonia increased | FAERS: 4 | US FAERS | |
| 120 | Blood albumin decreased | FAERS: 4 | OFFSIDES US FAERS | |
| 121 | Blood cholesterol increased | FAERS: 4 | US FAERS | |
| 122 | Blood creatine phosphokinase MB increased | FAERS: 4 | OFFSIDES US FAERS | |
| 123 | Blood urine present | FAERS: 4 | US FAERS | |
| 124 | Cholestasis | FAERS: 4 | US FAERS | |
| 125 | Dyspepsia | FAERS: 4 | US FAERS | |
| 126 | Electrocardiogram abnormal | FAERS: 4 | US FAERS | |
| 127 | Guillain-Barre Syndrome | FAERS: 4 | US FAERS | |
| 128 | Hepatitis B virus test positive | FAERS: 4 | US FAERS | |
| 129 | Hepatorenal Syndrome | FAERS: 4 | US FAERS | |
| 130 | Hepatotoxicity | FAERS: 4 | OFFSIDES US FAERS | |
| 131 | Impaired work ability | FAERS: 4 | US FAERS | |
| 132 | Muscle Fatigue | FAERS: 4 | US FAERS | |
| 133 | Nasopharyngitis | FAERS: 4 | US FAERS | |
| 134 | Pancreatitis | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 135 | Pancytopenia | FAERS: 4 | US FAERS | |
| 136 | Plasmacytoma | FAERS: 4 | US FAERS | |
| 137 | Product storage error | FAERS: 4 | US FAERS | |
| 138 | Septic Shock | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 139 | Somnolence | FAERS: 4 | US FAERS | |
| 140 | Squamous cell carcinoma | FAERS: 4 | US FAERS | |
| 141 | Stillbirth | FAERS: 4 | US FAERS | |
| 142 | Swelling | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 143 | Traumatic fracture | FAERS: 4 | US FAERS | |
| 144 | Vertigo | FAERS: 4 | US FAERS | |
| 145 | Viral mutation identified | FAERS: 4 | US FAERS | |
| 146 | Visual Impairment | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 147 | treatment failure | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 148 | Activities of daily living impaired | FAERS: 3 | US FAERS | |
| 149 | Alanine aminotransferase abnormal | FAERS: 3 | OFFSIDES US FAERS | |
| 150 | Ankle Fracture | FAERS: 3 | OFFSIDES US FAERS | |
| 151 | Anorexia | FAERS: 3 | US FAERS | |
| 152 | Arthritis | FAERS: 3 | US FAERS | |
| 153 | Blood alkaline phosphatase increased | FAERS: 3 | OFFSIDES US FAERS | |
| 154 | Blood urea increased | FAERS: 3 | US FAERS | |
| 155 | Bone density abnormal | FAERS: 3 | US FAERS | |
| 156 | Cholelithiasis | FAERS: 3 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 157 | Cholestasis of pregnancy | FAERS: 3 | OFFSIDES US FAERS | |
| 158 | Dementia | FAERS: 3 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 159 | Diabetes Insipidus | FAERS: 3 | OFFSIDES US FAERS | |
| 160 | Disability | FAERS: 3 | US FAERS | |
| 161 | Drug dispensing error | FAERS: 3 | US FAERS | |
| 162 | Dysgeusia | FAERS: 3 | US FAERS | |
| 163 | Electrolyte imbalance | FAERS: 3 | US FAERS | |
| 164 | Epigastric discomfort | FAERS: 3 | US FAERS | |
| 165 | Erythema Multiforme | FAERS: 3 | US FAERS | |
| 166 | Feeling abnormal | FAERS: 3 | US FAERS | |
| 167 | Gastroenteritis | FAERS: 3 | OFFSIDES US FAERS | |
| 168 | Glycosuria | FAERS: 3 | US FAERS | |
| 169 | Hydronephrosis | FAERS: 3 | OFFSIDES US FAERS | |
| 170 | Incorrect product storage | FAERS: 3 | US FAERS | |
| 171 | Leukopenia | FAERS: 3 | US FAERS | |
| 172 | Limb injury | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 173 | Medication Error | FAERS: 3 | US FAERS | |
| 174 | Mitochondrial cytopathy | FAERS: 3 | US FAERS | |
| 175 | Nervousness | FAERS: 3 | US FAERS | |
| 176 | No adverse event | FAERS: 3 | US FAERS | |
| 177 | Pathogen resistance | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 178 | Peptic Ulcer | FAERS: 3 | US FAERS | |
| 179 | Polyuria | FAERS: 3 | OFFSIDES US FAERS | |
| 180 | Portal Hypertension | FAERS: 3 | OFFSIDES US FAERS | |
| 181 | Product dispensing error | FAERS: 3 | US FAERS | |
| 182 | Psoriasis | FAERS: 3 | US FAERS | |
| 183 | Renal cyst | FAERS: 3 | US FAERS | |
| 184 | Respiratory Failure | FAERS: 3 | US FAERS | |
| 185 | Respiratory distress | FAERS: 3 | US FAERS | |
| 186 | Rheumatoid Arthritis | FAERS: 3 | US FAERS | |
| 187 | Syncope | FAERS: 3 | US FAERS | |
| 188 | Therapeutic response unexpected | FAERS: 3 | US FAERS | |
| 189 | Tinnitus | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 190 | Transplant | FAERS: 3 | US FAERS | |
| 191 | Urinary tract infection | FAERS: 3 | US FAERS | |
| 192 | Virologic failure | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 193 | White blood cell count decreased | FAERS: 3 | US FAERS | |
| 194 | Abasia | FAERS: 2 | US FAERS | |
| 195 | Abscess | FAERS: 2 | US FAERS | |
| 196 | Agitation | FAERS: 2 | US FAERS | |
| 197 | Angina Pectoris | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 198 | Angioedema | FAERS: 2 | OFFSIDES US FAERS | |
| 199 | Angiolipoma | FAERS: 2 | US FAERS | |
| 200 | Aspartate aminotransferase abnormal | FAERS: 2 | OFFSIDES US FAERS | |
| 201 | Blood HIV RNA increased | FAERS: 2 | US FAERS | |
| 202 | Blood albumin increased | FAERS: 2 | US FAERS | |
| 203 | Blood glucose decreased | FAERS: 2 | US FAERS | |
| 204 | Blood lactate dehydrogenase increased | FAERS: 2 | OFFSIDES US FAERS | |
| 205 | Blood phosphorus increased | FAERS: 2 | OFFSIDES US FAERS | |
| 206 | Blood potassium increased | FAERS: 2 | US FAERS | |
| 207 | Cachexia | FAERS: 2 | US FAERS | |
| 208 | Cerebral Infarction | FAERS: 2 | US FAERS | |
| 209 | Chest discomfort | FAERS: 2 | US FAERS | |
| 210 | Completed Suicide | FAERS: 2 | US FAERS | |
| 211 | Crying | FAERS: 2 | US FAERS | |
| 212 | Diabetic Nephropathy | FAERS: 2 | US FAERS | |
| 213 | Discomfort | FAERS: 2 | US FAERS | |
| 214 | Disease Progression | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 215 | Drug level increased | FAERS: 2 | US FAERS | |
| 216 | Drug toxicity | FAERS: 2 | US FAERS | |
| 217 | Facial wasting | FAERS: 2 | OFFSIDES US FAERS | |
| 218 | Fat redistribution | FAERS: 2 | OFFSIDES US FAERS | |
| 219 | Feeding tube user | FAERS: 2 | US FAERS | |
| 220 | Feeling jittery | FAERS: 2 | US FAERS | |
| 221 | Fragile X Syndrome | FAERS: 2 | US FAERS | |
| 222 | General physical condition | FAERS: 2 | OFFSIDES US FAERS | |
| 223 | Glomerulonephritis | FAERS: 2 | OFFSIDES US FAERS | |
| 224 | Hepatectomy | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 225 | Hepatitis C | FAERS: 2 | OFFSIDES US FAERS | |
| 226 | Hernia | FAERS: 2 | US FAERS | |
| 227 | Hypercalciuria | FAERS: 2 | US FAERS | |
| 228 | Hypophagia | FAERS: 2 | US FAERS | |
| 229 | Hypospadias | FAERS: 2 | OFFSIDES US FAERS | |
| 230 | Hypotension | FAERS: 2 | US FAERS | |
| 231 | Hypothyroidism | FAERS: 2 | US FAERS | |
| 232 | Infection | FAERS: 2 | US FAERS | |
| 233 | Insulin Resistance | FAERS: 2 | US FAERS | |
| 234 | Intentional drug misuse | FAERS: 2 | US FAERS | |
| 235 | Intentional product misuse | FAERS: 2 | US FAERS | |
| 236 | Intervertebral Disc Degeneration | FAERS: 2 | US FAERS | |
| 237 | Intestinal metaplasia | FAERS: 2 | US FAERS | |
| 238 | Intestinal scarring | FAERS: 2 | US FAERS | |
| 239 | Joint stiffness | FAERS: 2 | US FAERS | |
| 240 | Lipohypertrophy | FAERS: 2 | OFFSIDES US FAERS | |
| 241 | Low birth weight baby | FAERS: 2 | US FAERS | |
| 242 | Lymphocyte count decreased | FAERS: 2 | US FAERS | |
| 243 | Maternal exposure timing unspecified | FAERS: 2 | US FAERS | |
| 244 | Monocyte count decreased | FAERS: 2 | US FAERS | |
| 245 | Myopathy | FAERS: 2 | US FAERS | |
| 246 | Neck Pain | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 247 | Neutrophil count decreased | FAERS: 2 | US FAERS | |
| 248 | Night sweats | FAERS: 2 | US FAERS | |
| 249 | Nodule | FAERS: 2 | US FAERS | |
| 250 | Osteosclerosis | FAERS: 2 | US FAERS | |
| 251 | Pancreatic carcinoma | FAERS: 2 | US FAERS | |
| 252 | Paternal exposure before pregnancy | FAERS: 2 | US FAERS | |
| 253 | Portal Vein Thrombosis | FAERS: 2 | US FAERS | |
| 254 | Product difficult to swallow | FAERS: 2 | US FAERS | |
| 255 | Product substitution issue | FAERS: 2 | US FAERS | |
| 256 | Product taste abnormal | FAERS: 2 | US FAERS | |
| 257 | Productive Cough | FAERS: 2 | US FAERS | |
| 258 | Protein urine present | FAERS: 2 | US FAERS | |
| 259 | Pyelonephritis | FAERS: 2 | US FAERS | |
| 260 | Renal Colic | FAERS: 2 | OFFSIDES US FAERS | |
| 261 | Rickets | FAERS: 2 | OFFSIDES US FAERS | |
| 262 | Schizophrenia | FAERS: 2 | US FAERS | |
| 263 | Sexual Dysfunction | FAERS: 2 | US FAERS | |
| 264 | Shock | FAERS: 2 | US FAERS | |
| 265 | Sinus headache | FAERS: 2 | US FAERS | |
| 266 | Sinusitis | FAERS: 2 | US FAERS | |
| 267 | Spermatozoa abnormal | FAERS: 2 | US FAERS | |
| 268 | Spermatozoa progressive motility decreased | FAERS: 2 | US FAERS | |
| 269 | Stress at work | FAERS: 2 | US FAERS | |
| 270 | Suspected counterfeit product | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 271 | Synovitis | FAERS: 2 | US FAERS | |
| 272 | Thrombocytopenic purpura | FAERS: 2 | US FAERS | |
| 273 | Thrombosis | FAERS: 2 | US FAERS | |
| 274 | Toxicity to various agents | FAERS: 2 | US FAERS | |
| 275 | Transaminases increased | FAERS: 2 | OFFSIDES US FAERS | |
| 276 | Typhoid Fever | FAERS: 2 | US FAERS | |
| 277 | Urinary Retention | FAERS: 2 | US FAERS | |
| 278 | Urine albumin/creatinine ratio increased | FAERS: 2 | US FAERS | |
| 279 | Urine phosphorus abnormal | FAERS: 2 | US FAERS | |
| 280 | Urine uric acid abnormal | FAERS: 2 | US FAERS | |
| 281 | Viral load decreased | FAERS: 2 | OFFSIDES US FAERS | |
| 282 | Viral test positive | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 283 | nervous system disorder | FAERS: 2 | US FAERS | |
| 284 | Abdominal symptom | FAERS: 1 | US FAERS | |
| 285 | Accidental exposure to product by child | FAERS: 1 | US FAERS | |
| 286 | Acidosis | FAERS: 1 | OFFSIDES US FAERS | |
| 287 | Acne | FAERS: 1 | US FAERS | |
| 288 | Acquired Immunodeficiency Syndrome | FAERS: 1 | US FAERS | |
| 289 | Adverse event | FAERS: 1 | US FAERS | |
| 290 | Agranulocytosis | FAERS: 1 | US FAERS | |
| 291 | Amylase increased | FAERS: 1 | US FAERS | |
| 292 | Amyotrophic Lateral Sclerosis | FAERS: 1 | US FAERS | |
| 293 | Anaphylactic shock | FAERS: 1 | US FAERS | |
| 294 | Anencephaly | FAERS: 1 | US FAERS | |
| 295 | Aneurysm | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 296 | Antibody test positive | FAERS: 1 | US FAERS | |
| 297 | Aphagia | FAERS: 1 | US FAERS | |
| 298 | Aphonia | FAERS: 1 | US FAERS | |
| 299 | Aphthous Stomatitis | FAERS: 1 | US FAERS | |
| 300 | Appendicitis | FAERS: 1 | US FAERS | |
| 301 | Arterial restenosis | FAERS: 1 | US FAERS | |
| 302 | Ataxia | FAERS: 1 | US FAERS | |
| 303 | Atrial Fibrillation | FAERS: 1 | US FAERS | |
| 304 | Atypical femur fracture | FAERS: 1 | US FAERS | |
| 305 | Back disorder | FAERS: 1 | US FAERS | |
| 306 | Bipolar Disorder | FAERS: 1 | US FAERS | |
| 307 | Blepharospasm | FAERS: 1 | US FAERS | |
| 308 | Blood bilirubin abnormal | FAERS: 1 | US FAERS | |
| 309 | Blood cholesterol abnormal | FAERS: 1 | US FAERS | |
| 310 | Blood creatine decreased | FAERS: 1 | US FAERS | |
| 311 | Blood creatinine decreased | FAERS: 1 | US FAERS | |
| 312 | Blood magnesium decreased | FAERS: 1 | US FAERS | |
| 313 | Blood phosphorus abnormal | FAERS: 1 | US FAERS | |
| 314 | Blood potassium decreased | FAERS: 1 | US FAERS | |
| 315 | Blood sodium decreased | FAERS: 1 | US FAERS | |
| 316 | Blood triglycerides increased | FAERS: 1 | OFFSIDES US FAERS | |
| 317 | Bone fissure | FAERS: 1 | OFFSIDES US FAERS | |
| 318 | Bradycardia | FAERS: 1 | US FAERS | |
| 319 | Breast cancer stage II | FAERS: 1 | US FAERS | |
| 320 | Cataract | FAERS: 1 | US FAERS | |
| 321 | Cellulitis | FAERS: 1 | US FAERS | |
| 322 | Cerebellar artery thrombosis | FAERS: 1 | US FAERS | |
| 323 | Cerebral Palsy | FAERS: 1 | US FAERS | |
| 324 | Cerebral disorder | FAERS: 1 | US FAERS | |
| 325 | Cheilitis | FAERS: 1 | US FAERS | |
| 326 | Cholecystitis | FAERS: 1 | OFFSIDES US FAERS | |
| 327 | Chronic respiratory failure | FAERS: 1 | US FAERS | |
| 328 | Circumstance or information capable of leading to medication error | FAERS: 1 | OFFSIDES US FAERS | |
| 329 | Cleft Palate | FAERS: 1 | US FAERS | |
| 330 | Clostridium difficile colitis | FAERS: 1 | US FAERS | |
| 331 | Colectomy | FAERS: 1 | US FAERS | |
| 332 | Colitis | FAERS: 1 | US FAERS | |
| 333 | Congenital cystic kidney disease | FAERS: 1 | US FAERS | |
| 334 | Congenital intestinal malformation | FAERS: 1 | US FAERS | |
| 335 | Coronary Artery Disease | FAERS: 1 | US FAERS | |
| 336 | Creatinine renal clearance increased | FAERS: 1 | US FAERS | |
| 337 | Crystal urine present | FAERS: 1 | US FAERS | |
| 338 | Deep Vein Thrombosis | FAERS: 1 | US FAERS | |
| 339 | Dehiscence | FAERS: 1 | US FAERS | |
| 340 | Delirium | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 341 | Device Failure | FAERS: 1 | US FAERS | |
| 342 | Device related infection | FAERS: 1 | US FAERS | |
| 343 | Diaphragmatic Hernia | FAERS: 1 | OFFSIDES US FAERS | |
| 344 | Diffuse Large B-Cell Lymphoma | FAERS: 1 | OFFSIDES US FAERS | |
| 345 | Drug administration error | FAERS: 1 | US FAERS | |
| 346 | Drug prescribing error | FAERS: 1 | US FAERS | |
| 347 | Duodenal Ulcer | FAERS: 1 | US FAERS | |
| 348 | Dysbacteriosis | FAERS: 1 | US FAERS | |
| 349 | Dysentery | FAERS: 1 | US FAERS | |
| 350 | Electrocardiogram change | FAERS: 1 | US FAERS | |
| 351 | Empyema | FAERS: 1 | OFFSIDES US FAERS | |
| 352 | Enchondroma | FAERS: 1 | US FAERS | |
| 353 | Endometriosis | FAERS: 1 | US FAERS | |
| 354 | Enzyme level increased | FAERS: 1 | US FAERS | |
| 355 | Epilepsy | FAERS: 1 | US FAERS | |
| 356 | Erythema | FAERS: 1 | US FAERS | |
| 357 | Escherichia infection | FAERS: 1 | US FAERS | |
| 358 | Exposure via breast milk | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 359 | Exposure via father | FAERS: 1 | US FAERS | |
| 360 | Extra dose administered | FAERS: 1 | US FAERS | |
| 361 | Eye pain | FAERS: 1 | US FAERS | |
| 362 | Facial paralysis | FAERS: 1 | US FAERS | |
| 363 | False positive investigation result | FAERS: 1 | US FAERS | |
| 364 | Gamma-Glutamyltransferase Increased | FAERS: 1 | OFFSIDES US FAERS | |
| 365 | Gastrointestinal Pain | FAERS: 1 | US FAERS | |
| 366 | Gastrointestinal sounds abnormal | FAERS: 1 | US FAERS | |
| 367 | Gastrostomy | FAERS: 1 | US FAERS | |
| 368 | Gingivitis | FAERS: 1 | US FAERS | |
| 369 | Head discomfort | FAERS: 1 | US FAERS | |
| 370 | Hepatic Encephalopathy | FAERS: 1 | US FAERS | |
| 371 | Hepatic necrosis | FAERS: 1 | US FAERS | |
| 372 | Hepatitis A | FAERS: 1 | OFFSIDES US FAERS | |
| 373 | Hepatitis B e antigen positive | FAERS: 1 | US FAERS | |
| 374 | Hepatitis E antigen negative | FAERS: 1 | US FAERS | |
| 375 | Hip surgery | FAERS: 1 | US FAERS | |
| 376 | Homicide | FAERS: 1 | US FAERS | |
| 377 | Hydrocephalus | FAERS: 1 | OFFSIDES US FAERS | |
| 378 | Hyperemesis Gravidarum | FAERS: 1 | US FAERS | |
| 379 | Hyperparathyroidism | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 380 | Hyperthyroidism | FAERS: 1 | US FAERS | |
| 381 | Hypokinesia | FAERS: 1 | US FAERS | |
| 382 | Hyporeflexia | FAERS: 1 | OFFSIDES US FAERS | |
| 383 | Hypoxia | FAERS: 1 | US FAERS | |
| 384 | Hysterectomy | FAERS: 1 | US FAERS | |
| 385 | Idiopathic angioedema | FAERS: 1 | US FAERS | |
| 386 | Ileus | FAERS: 1 | US FAERS | |
| 387 | Impaired gastric emptying | FAERS: 1 | US FAERS | |
| 388 | Inappropriate schedule of drug administration | FAERS: 1 | US FAERS | |
| 389 | Incision site pain | FAERS: 1 | US FAERS | |
| 390 | Incorrect dose administered | FAERS: 1 | US FAERS | |
| 391 | Infarction | FAERS: 1 | US FAERS | |
| 392 | Influenza | FAERS: 1 | US FAERS | |
| 393 | Intestinal Obstruction | FAERS: 1 | US FAERS | |
| 394 | Intra-abdominal fluid collection | FAERS: 1 | US FAERS | |
| 395 | Intracranial Aneurysm | FAERS: 1 | US FAERS | |
| 396 | Joint injury | FAERS: 1 | US FAERS | |
| 397 | Leukoencephalopathy | FAERS: 1 | US FAERS | |
| 398 | Ligament injury | FAERS: 1 | US FAERS | |
| 399 | Ligament pain | FAERS: 1 | US FAERS | |
| 400 | Lip swelling | FAERS: 1 | US FAERS | |
| 401 | Lipase increased | FAERS: 1 | US FAERS | |
| 402 | Lipoma | FAERS: 1 | US FAERS | |
| 403 | Loose tooth | FAERS: 1 | US FAERS | |
| 404 | Lower respiratory tract infection | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 405 | Lupus-like syndrome | FAERS: 1 | US FAERS | |
| 406 | Lymphadenopathy | FAERS: 1 | US FAERS | |
| 407 | MYELODYSPLASTIC SYNDROME | FAERS: 1 | US FAERS | |
| 408 | Macrocytosis | FAERS: 1 | US FAERS | |
| 409 | Macular pigmentation | FAERS: 1 | US FAERS | |
| 410 | Malabsorption | FAERS: 1 | OFFSIDES US FAERS | |
| 411 | Malignant Glioma | FAERS: 1 | US FAERS | |
| 412 | Malnutrition | FAERS: 1 | US FAERS | |
| 413 | Marasmus | FAERS: 1 | US FAERS | |
| 414 | Mastitis | FAERS: 1 | US FAERS | |
| 415 | Meningitis | FAERS: 1 | US FAERS | |
| 416 | Metaplasia | FAERS: 1 | US FAERS | |
| 417 | Metastatic Neoplasm | FAERS: 1 | US FAERS | |
| 418 | Metrorrhagia | FAERS: 1 | US FAERS | |
| 419 | Microalbuminuria | FAERS: 1 | US FAERS | |
| 420 | Model for end stage liver disease score increased | FAERS: 1 | US FAERS | |
| 421 | Mouth swelling | FAERS: 1 | US FAERS | |
| 422 | Muscle tightness | FAERS: 1 | US FAERS | |
| 423 | Musculoskeletal discomfort | FAERS: 1 | US FAERS | |
| 424 | Myasthenia Gravis | FAERS: 1 | US FAERS | |
| 425 | Myelofibrosis | FAERS: 1 | US FAERS | |
| 426 | Myocardial necrosis marker increased | FAERS: 1 | US FAERS | |
| 427 | Myositis | FAERS: 1 | US FAERS | |
| 428 | Nephritic syndrome | FAERS: 1 | OFFSIDES US FAERS | |
| 429 | Nerve injury | FAERS: 1 | US FAERS | |
| 430 | Neuralgia | FAERS: 1 | US FAERS | |
| 431 | Neurocryptococcosis | FAERS: 1 | US FAERS | |
| 432 | Nocturia | FAERS: 1 | US FAERS | |
| 433 | Obsessive-Compulsive Disorder | FAERS: 1 | US FAERS | |
| 434 | Obstruction | FAERS: 1 | OFFSIDES US FAERS | |
| 435 | Occupational exposure to product | FAERS: 1 | US FAERS | |
| 436 | Ocular icterus | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 437 | Oligohydramnios | FAERS: 1 | US FAERS | |
| 438 | Oncologic complication | FAERS: 1 | US FAERS | |
| 439 | Onychoclasis | FAERS: 1 | US FAERS | |
| 440 | Optic Neuritis | FAERS: 1 | US FAERS | |
| 441 | Oral pain | FAERS: 1 | US FAERS | |
| 442 | Orchitis | FAERS: 1 | OFFSIDES US FAERS | |
| 443 | Osteonecrosis of Jaw | FAERS: 1 | US FAERS | |
| 444 | Osteosarcoma | FAERS: 1 | US FAERS | |
| 445 | Ototoxicity | FAERS: 1 | US FAERS | |
| 446 | Ovarian fibrosis | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 447 | Oxygen saturation abnormal | FAERS: 1 | US FAERS | |
| 448 | Pancreatic Cyst | FAERS: 1 | US FAERS | |
| 449 | Papule | FAERS: 1 | US FAERS | |
| 450 | Paternal exposure timing unspecified | FAERS: 1 | US FAERS | |
| 451 | Pelvic Inflammatory Disease | FAERS: 1 | US FAERS | |
| 452 | Pericardial effusion | FAERS: 1 | OFFSIDES US FAERS | |
| 453 | Perinatal HBV infection | FAERS: 1 | US FAERS | |
| 454 | Periostitis | FAERS: 1 | OFFSIDES US FAERS | |
| 455 | Peripheral artery occlusion | FAERS: 1 | US FAERS | |
| 456 | Pharyngolaryngeal Pain | FAERS: 1 | OFFSIDES US FAERS | |
| 457 | Photophobia | FAERS: 1 | US FAERS | |
| 458 | Platelet Transfusion | FAERS: 1 | US FAERS | |
| 459 | Pneumothorax | FAERS: 1 | US FAERS | |
| 460 | Polyhydramnios | FAERS: 1 | US FAERS | |
| 461 | Poor quality drug administered | FAERS: 1 | US FAERS | |
| 462 | Post procedural complication | FAERS: 1 | US FAERS | |
| 463 | Posterior reversible encephalopathy syndrome | FAERS: 1 | US FAERS | |
| 464 | Pre-Eclampsia | FAERS: 1 | US FAERS | |
| 465 | Prealbumin abnormal | FAERS: 1 | US FAERS | |
| 466 | Product dose omission | FAERS: 1 | US FAERS | |
| 467 | Product quality issue | FAERS: 1 | US FAERS | |
| 468 | Product use complaint | FAERS: 1 | US FAERS | |
| 469 | Prothrombin level decreased | FAERS: 1 | OFFSIDES US FAERS | |
| 470 | Pulmonary malformation | FAERS: 1 | US FAERS | |
| 471 | Quality of life decreased | FAERS: 1 | US FAERS | |
| 472 | Reflux gastritis | FAERS: 1 | US FAERS | |
| 473 | Regurgitation | FAERS: 1 | US FAERS | |
| 474 | Renal Cell Carcinoma | FAERS: 1 | US FAERS | |
| 475 | Renal mass | FAERS: 1 | OFFSIDES US FAERS | |
| 476 | Renal pain | FAERS: 1 | US FAERS | |
| 477 | Renal salt-wasting syndrome | FAERS: 1 | US FAERS | |
| 478 | Renal transplant failure | FAERS: 1 | US FAERS | |
| 479 | Retinal Detachment | FAERS: 1 | US FAERS | |
| 480 | Retinal toxicity | FAERS: 1 | US FAERS | |
| 481 | Single functional kidney | FAERS: 1 | US FAERS | |
| 482 | Sinus rhythm | FAERS: 1 | US FAERS | |
| 483 | Slow speech | FAERS: 1 | US FAERS | |
| 484 | Solar lentigo | FAERS: 1 | US FAERS | |
| 485 | Splenectomy | FAERS: 1 | US FAERS | |
| 486 | Splenomegaly | FAERS: 1 | US FAERS | |
| 487 | Stevens-Johnson Syndrome | FAERS: 1 | US FAERS | |
| 488 | Stress | FAERS: 1 | US FAERS | |
| 489 | Subacute hepatic failure | FAERS: 1 | US FAERS | |
| 490 | Tachycardia | FAERS: 1 | US FAERS | |
| 491 | Talipes | FAERS: 1 | OFFSIDES US FAERS | |
| 492 | Terminal state | FAERS: 1 | US FAERS | |
| 493 | Thalamic infarction | FAERS: 1 | US FAERS | |
| 494 | Therapy change | FAERS: 1 | US FAERS | |
| 495 | Therapy non-responder | FAERS: 1 | OFFSIDES US FAERS | |
| 496 | Thirst | FAERS: 1 | US FAERS | |
| 497 | Thyroid Neoplasm | FAERS: 1 | US FAERS | |
| 498 | Toothache | FAERS: 1 | US FAERS | |
| 499 | Total bile acids increased | FAERS: 1 | US FAERS | |
| 500 | Trisomy 21 | FAERS: 1 | OFFSIDES US FAERS | |
| 501 | Tuberculosis | FAERS: 1 | US FAERS | |
| 502 | Umbilical hernia | FAERS: 1 | US FAERS | |
| 503 | Ureterolithiasis | FAERS: 1 | US FAERS | |
| 504 | Urine phosphorus increased | FAERS: 1 | US FAERS | |
| 505 | Vasculitis | FAERS: 1 | US FAERS | |
| 506 | Ventricular hypoplasia | FAERS: 1 | OFFSIDES US FAERS | |
| 507 | Vitreous Detachment | FAERS: 1 | US FAERS | |
| 508 | Wheelchair user | FAERS: 1 | US FAERS | |
| 509 | Wheezing | FAERS: 1 | US FAERS | |
| 510 | Wrong technique in drug usage process | FAERS: 1 | US FAERS | |
| 511 | cancer surgery | FAERS: 1 | US FAERS | |
| 512 | effusion | FAERS: 1 | US FAERS | |
| 513 | oligodendroglioma | FAERS: 1 | US FAERS | |
| 514 | ACTH stimulation test abnormal | OFFSIDES | ||
| 515 | AIDS related complication | OFFSIDES | ||
| 516 | Abdominal Infection | OFFSIDES | ||
| 517 | Abdominal sepsis | OFFSIDES | ||
| 518 | Abuse | OFFSIDES | ||
| 519 | Acholia | OFFSIDES | ||
| 520 | Acid fast bacilli infection | OFFSIDES | ||
| 521 | Acoustic stimulation tests abnormal | OFFSIDES | ||
| 522 | Acute psychosis | OFFSIDES | ||
| 523 | Adrenal cyst | OFFSIDES | ||
| 524 | Adrenogenital Syndrome | OFFSIDES | ||
| 525 | Albuminuria | OFFSIDES | ||
| 526 | Alcohol withdrawal syndrome | OFFSIDES | ||
| 527 | Aminoaciduria | OFFSIDES | ||
| 528 | Anisocoria | OFFSIDES | ||
| 529 | Anogenital dysplasia | OFFSIDES | ||
| 530 | Arthropod bite | OFFSIDES | ||
| 531 | Asterixis | OFFSIDES | ||
| 532 | Atrophy of tongue papillae | OFFSIDES | ||
| 533 | Bedridden | Canada Vigilance: 1 | Canada Vigilance | |
| 534 | Biopsy bone marrow abnormal | OFFSIDES | ||
| 535 | Biopsy liver abnormal | OFFSIDES | ||
| 536 | Blepharoptosis | OFFSIDES | ||
| 537 | Blighted ovum | OFFSIDES | ||
| 538 | Blood 1,25-dihydroxycholecalciferol decreased | OFFSIDES | ||
| 539 | Blood HIV RNA | OFFSIDES | ||
| 540 | Blood alkaline phosphatase abnormal | OFFSIDES | ||
| 541 | Blood amylase increased | OFFSIDES | ||
| 542 | Blood antidiuretic hormone increased | OFFSIDES | ||
| 543 | Blood bicarbonate abnormal | OFFSIDES | ||
| 544 | Blood corticotrophin | OFFSIDES | ||
| 545 | Blood cortisol decreased | OFFSIDES | ||
| 546 | Blood creatine increased | OFFSIDES | ||
| 547 | Blood erythropoietin abnormal | OFFSIDES | ||
| 548 | Blood immunoglobulin A increased | OFFSIDES | ||
| 549 | Blood immunoglobulin G increased | OFFSIDES | ||
| 550 | Blood immunoglobulin M | OFFSIDES | ||
| 551 | Blood insulin decreased | OFFSIDES | ||
| 552 | Blood iron increased | OFFSIDES | ||
| 553 | Blood lactic acid abnormal | OFFSIDES | ||
| 554 | Blood lactic acid decreased | OFFSIDES | ||
| 555 | Blood parathyroid hormone increased | OFFSIDES | ||
| 556 | Blood phosphorus | OFFSIDES | ||
| 557 | Blood uric acid decreased | OFFSIDES | ||
| 558 | Blood uric acid | OFFSIDES | ||
| 559 | Body Temperature | OFFSIDES | ||
| 560 | Bone infarction | OFFSIDES | ||
| 561 | Bone marrow necrosis | OFFSIDES | ||
| 562 | Bone marrow toxicity | OFFSIDES | ||
| 563 | Bowen's Disease | OFFSIDES | ||
| 564 | Brain stem syndrome | OFFSIDES | ||
| 565 | Bulimia | OFFSIDES | ||
| 566 | CD4 lymphocytes increased | OFFSIDES | ||
| 567 | CD8 lymphocytes decreased | OFFSIDES | ||
| 568 | Calcification pancreatic duct | OFFSIDES | ||
| 569 | Calcinosis | OFFSIDES | ||
| 570 | Cardiac Tamponade | OFFSIDES | ||
| 571 | Carnitine decreased | OFFSIDES | ||
| 572 | Cell Death | OFFSIDES | ||
| 573 | Cerebellar Hypoplasia | OFFSIDES | ||
| 574 | Cerebral hygroma | OFFSIDES | ||
| 575 | Ceruloplasmin decreased | OFFSIDES | ||
| 576 | Cervical myelopathy | OFFSIDES | ||
| 577 | Chest wall pain | OFFSIDES | ||
| 578 | Cholangiolitis | OFFSIDES | ||
| 579 | Choroiditis | OFFSIDES | ||
| 580 | Cirrhosis | OFFSIDES | ||
| 581 | Complications of maternal exposure to therapeutic drugs | OFFSIDES | ||
| 582 | Congenital Hydrocephalus | OFFSIDES | ||
| 583 | Congenital abdominal hernia | OFFSIDES | ||
| 584 | Congenital hypertrichosis | OFFSIDES | ||
| 585 | Congenital mitochondrial cytopathy | OFFSIDES | ||
| 586 | Congenital neurological disorder | OFFSIDES | ||
| 587 | Congenital pyelocaliectasis | OFFSIDES | ||
| 588 | Congenital teratoma | OFFSIDES | ||
| 589 | Congenital urinary tract obstruction | OFFSIDES | ||
| 590 | Cortisol free urine decreased | OFFSIDES | ||
| 591 | Creatinine urine decreased | OFFSIDES | ||
| 592 | Cryptorchidism | OFFSIDES | ||
| 593 | Cryptosporidiosis | OFFSIDES | ||
| 594 | Crystalluria | OFFSIDES | ||
| 595 | Cyst | OFFSIDES | ||
| 596 | Cytolytic hepatitis | OFFSIDES | ||
| 597 | Cytomegalovirus chorioretinitis | OFFSIDES | ||
| 598 | Demyelination | OFFSIDES | ||
| 599 | Depressed mood | OFFSIDES | ||
| 600 | Diabetes | OFFSIDES | ||
| 601 | Diarrhea | OFFSIDES | ||
| 602 | Diplopia | OFFSIDES | ||
| 603 | Double ureter | OFFSIDES | ||
| 604 | Ear discomfort | OFFSIDES | ||
| 605 | Electrocardiogram U-wave abnormality | OFFSIDES | ||
| 606 | End stage AIDS | OFFSIDES | ||
| 607 | Enterocolitis AIDS | OFFSIDES | ||
| 608 | Enthesopathy | OFFSIDES | ||
| 609 | Eosinophilic myocarditis | OFFSIDES | ||
| 610 | Epididymitis | OFFSIDES | ||
| 611 | Epidural lipomatosis | OFFSIDES | ||
| 612 | Erythropenia | OFFSIDES | ||
| 613 | Escherichia sepsis | OFFSIDES | ||
| 614 | Eustachian tube disorder | OFFSIDES | ||
| 615 | Facial Neuralgia | OFFSIDES | ||
| 616 | Factor VIII Deficiency | OFFSIDES | ||
| 617 | Fatty Liver | OFFSIDES | ||
| 618 | Fluid overload | OFFSIDES | ||
| 619 | Gait inability | Canada Vigilance: 1 | Canada Vigilance | |
| 620 | Gallop rhythm present | OFFSIDES | ||
| 621 | Gastrointestinal motility disorder | OFFSIDES | ||
| 622 | Gastrointestinal toxicity | OFFSIDES | ||
| 623 | Gastroschisis | OFFSIDES | ||
| 624 | Gaze palsy | OFFSIDES | ||
| 625 | Gene Mutation | Canada Vigilance: 1 | Canada Vigilance | |
| 626 | Glioma | OFFSIDES | ||
| 627 | Globulinuria | OFFSIDES | ||
| 628 | Glycogen Storage Disease Type I | OFFSIDES | ||
| 629 | Granulomatous liver disease | OFFSIDES | ||
| 630 | HBV DNA increased | OFFSIDES | ||
| 631 | HIV Wasting Syndrome | OFFSIDES | ||
| 632 | Haematotoxicity | OFFSIDES | ||
| 633 | Hemiparesis | OFFSIDES | ||
| 634 | Hepatitis B DNA decreased | Canada Vigilance: 1 | Canada Vigilance | |
| 635 | Hepatitis B Virus | OFFSIDES | ||
| 636 | Hepatitis B positive | OFFSIDES | ||
| 637 | Hepatitis C RNA | OFFSIDES | ||
| 638 | Hepatitis E | OFFSIDES | ||
| 639 | Hepatojugular reflux | OFFSIDES | ||
| 640 | Hepatosplenomegaly | OFFSIDES | ||
| 641 | Hip Dysplasia | OFFSIDES | ||
| 642 | Hydroxycorticosteroids increased | OFFSIDES | ||
| 643 | Hyperphosphaturia | OFFSIDES | ||
| 644 | Iatrogenic injury | OFFSIDES | ||
| 645 | Immune reconstitution syndrome | OFFSIDES | ||
| 646 | Infusion site mobility decreased | OFFSIDES | ||
| 647 | Injection site burning | OFFSIDES | ||
| 648 | Injection site discomfort | OFFSIDES | ||
| 649 | Injection site erythema | OFFSIDES | ||
| 650 | Injection site fibrosis | OFFSIDES | ||
| 651 | Injection site mass | OFFSIDES | ||
| 652 | Injection site pruritus | OFFSIDES | ||
| 653 | Joint warmth | OFFSIDES | ||
| 654 | Keratitis sicca | OFFSIDES | ||
| 655 | Kidney Failure | OFFSIDES | ||
| 656 | Laryngeal erythema | OFFSIDES | ||
| 657 | Laryngomalacia | OFFSIDES | ||
| 658 | Laryngospasm | OFFSIDES | ||
| 659 | Left Ventricular Hypertrophy | OFFSIDES | ||
| 660 | Light chain analysis increased | OFFSIDES | ||
| 661 | Lipase | OFFSIDES | ||
| 662 | Lipids abnormal | OFFSIDES | ||
| 663 | Lipodystrophy acquired | OFFSIDES | ||
| 664 | Live Birth | OFFSIDES | ||
| 665 | Lymphocytic infiltration | OFFSIDES | ||
| 666 | Macroglossia | OFFSIDES | ||
| 667 | Macrophage Activation | OFFSIDES | ||
| 668 | Malabsorption from injection site | OFFSIDES | ||
| 669 | Malignant Hypertension | OFFSIDES | ||
| 670 | Malignant tumour excision | OFFSIDES | ||
| 671 | Mediastinal mass | OFFSIDES | ||
| 672 | Megakaryocytes increased | OFFSIDES | ||
| 673 | Meningocele | OFFSIDES | ||
| 674 | Mental retardation severity unspecified | OFFSIDES | ||
| 675 | Mesenteric artery stenosis | OFFSIDES | ||
| 676 | Microglossia | OFFSIDES | ||
| 677 | Mitochondrial DNA deletion | OFFSIDES | ||
| 678 | Mucocutaneous rash | OFFSIDES | ||
| 679 | Muscle abscess | OFFSIDES | ||
| 680 | Myoglobin blood increased | OFFSIDES | ||
| 681 | Neonatal respiratory distress | Canada Vigilance: 2 | Canada Vigilance | |
| 682 | Neuropathic ulcer | OFFSIDES | ||
| 683 | Neurosyphilis | OFFSIDES | ||
| 684 | No adverse effect | OFFSIDES | ||
| 685 | Nystagmus | OFFSIDES | ||
| 686 | Ophthalmoplegia | OFFSIDES | ||
| 687 | Optic Atrophy | OFFSIDES | ||
| 688 | Optic Disc Edema | OFFSIDES | ||
| 689 | Oropharyngeal candidiasis | OFFSIDES | ||
| 690 | Orthopnea | OFFSIDES | ||
| 691 | Osteitis Deformans | OFFSIDES | ||
| 692 | Pancreatic enzymes increased | OFFSIDES | ||
| 693 | Papilloma | OFFSIDES | ||
| 694 | Parvovirus B19 serology positive | OFFSIDES | ||
| 695 | Patellofemoral Pain Syndrome | OFFSIDES | ||
| 696 | Peripheral paralysis | OFFSIDES | ||
| 697 | Peritoneal Dialysis | OFFSIDES | ||
| 698 | Persistent left superior vena cava | OFFSIDES | ||
| 699 | Placental Insufficiency | OFFSIDES | ||
| 700 | Plagiocephaly | OFFSIDES | ||
| 701 | Pneumocystis jiroveci pneumonia | OFFSIDES | ||
| 702 | Poikilocytosis | OFFSIDES | ||
| 703 | Polymyositis | OFFSIDES | ||
| 704 | Portal hypertensive gastropathy | OFFSIDES | ||
| 705 | Product complaint | Canada Vigilance: 1 | Canada Vigilance | |
| 706 | Protein total increased | OFFSIDES | ||
| 707 | Psoas Abscess | OFFSIDES | ||
| 708 | Pulmonary Hypertension | OFFSIDES | ||
| 709 | Pulmonary Valve Stenosis | OFFSIDES | ||
| 710 | Pyelectasia | OFFSIDES | ||
| 711 | Renal interstitial fibrosis | OFFSIDES | ||
| 712 | Respiratory tract infection bacterial | OFFSIDES | ||
| 713 | Retinal Vein Occlusion | OFFSIDES | ||
| 714 | Retinitis | OFFSIDES | ||
| 715 | Schistosomiasis | OFFSIDES | ||
| 716 | Sense of oppression | OFFSIDES | ||
| 717 | Sick Sinus Syndrome | OFFSIDES | ||
| 718 | Skeleton dysplasia | OFFSIDES | ||
| 719 | Skin neoplasm excision | OFFSIDES | ||
| 720 | Spontaneous penile erection | OFFSIDES | ||
| 721 | Sputum culture positive | OFFSIDES | ||
| 722 | Staphylococcal abscess | OFFSIDES | ||
| 723 | Stent occlusion | OFFSIDES | ||
| 724 | Subcutaneous Abscess | OFFSIDES | ||
| 725 | Syphilis test positive | OFFSIDES | ||
| 726 | Syphilis | OFFSIDES | ||
| 727 | Tenosynovitis | OFFSIDES | ||
| 728 | Tetany | OFFSIDES | ||
| 729 | Therapeutic product effect decreased | Canada Vigilance: 1 | Canada Vigilance | |
| 730 | Thoracic vertebral fracture | OFFSIDES | ||
| 731 | Toxoplasmosis | OFFSIDES | ||
| 732 | Troponin increased | OFFSIDES | ||
| 733 | Ultrasound antenatal screen | OFFSIDES | ||
| 734 | Urine amphetamine positive | OFFSIDES | ||
| 735 | Urine calcium decreased | OFFSIDES | ||
| 736 | Urine electrolytes increased | OFFSIDES | ||
| 737 | Vanishing bile duct syndrome | OFFSIDES | ||
| 738 | Visual tracking test abnormal | OFFSIDES | ||
| 739 | Vitamin A Deficiency | OFFSIDES | ||
| 740 | Xerophthalmia | OFFSIDES | ||
| 741 | Zinc deficiency | OFFSIDES | ||
| 742 | furuncle | OFFSIDES | ||
| 743 | muscle injury | OFFSIDES | ||
| 744 | prostatitis | OFFSIDES |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.